Key result
Fenofibrate attenuated cardiac proteome alterations and restored signaling pathways negatively affected by 16 Gy local heart irradiation in mice.
Why the study?
Radiation-induced cardiovascular disease is associated with cardiac metabolic remodeling mainly due to PPARα inactivation, but whether PPARα agonist fenofibrate protects against radiation-induced cardiac toxicity was unknown.
Does fenofibrate attenuate cardiac proteome alterations in mice subjected to local heart irradiation?
Does fenofibrate attenuate cardiac proteome alterations in mice subjected to local heart irradiation?
Fenofibrate attenuates radiation-induced cardiac proteome alterations in a mouse model, suggesting a potential protective role against radiation-induced cardiovascular disease.
Hypothesis-generating for fenofibrate in radiation cardiotoxicity; clinical trials needed before any practice consideration.
Radiation-induced cardiovascular disease is associated with metabolic remodeling in the heart, mainly due to the inactivation of the transcription factor peroxisome proliferator-activated receptor alpha (PPARα), thereby inhibiting lipid metabolic enzymes. The objective of the present study was to investigate the potential protective effect of fenofibrate, a known agonist of PPARα on radiation-induced cardiac toxicity. To this end, we compared, for the first time, the cardiac proteome of fenofibrate- and placebo-treated mice 20 weeks after local heart irradiation (16 Gy) using label-free proteomics. The observations were further validated using immunoblotting, enzyme activity assays, and ELISA. The analysis showed that fenofibrate restored signalling pathways that were negatively affected by irradiation, including lipid metabolism, mitochondrial respiratory chain, redox response, tissue homeostasis, endothelial NO signalling and the inflammatory status. The results presented here indicate that PPARα activation by fenofibrate attenuates the cardiac proteome alterations induced by irradiation. These findings suggest a potential benefit of fenofibrate administration in the prevention of cardiovascular diseases, following radiation exposure.
No takes yet. Share an insight, caveat, or question.
Azimzadeh et al. (2021) studied Radiation-induced cardiac toxicity. Fenofibrate vs. Placebo was evaluated on Cardiac proteome alterations. Fenofibrate attenuated cardiac proteome alterations and restored signaling pathways negatively affected by 16 Gy local heart irradiation in mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: